Haemophilus influenzae type b disease in the era of conjugate vaccines: critical factors for successful eradication (original) (raw)
Safety and immunogenicity of an indigenously developed Haemophilus influenzae type b conjugate vaccine through various phases of clinical trials
Ashok Dutta
Human Vaccines, 2009
View PDFchevron_right
Global status of Haemophilus influenzae type b and pneumococcal conjugate vaccines: evidence, policies, and introductions
Nicholas Risko
Current Opinion in Infectious Diseases, 2010
View PDFchevron_right
Conjugate vaccines for preventing Haemophilus influenzae type b infections in children under 5 years of age
Fyezah Jehan, Yasir Shafiq
Protocols, 1996
View PDFchevron_right
The safety profile of Haemophilus influenzae type b– Neisseria meningitidis serogroups C and Y tetanus toxoid conjugate vaccine (HibMenCY)
Carlos Doniz
Human Vaccines & Immunotherapeutics, 2012
View PDFchevron_right
Safety and immunogenicity of two Haemophilus influenzae type b conjugate vaccines
Simonetta Viviani
South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 2004
View PDFchevron_right
Efficacy of Haemophilus Influenzae Type B Vaccine and Its Impact on the Representation of Causative Agents of Bacterial Meningitis in Children
Fatima Numanovic
The Central European Journal of Paediatrics, 2011
View PDFchevron_right
Progress in Vaccination against Haemophilus influenzae type b in the Americas
Andrus Garcia
PLOS Medicine, 2008
View PDFchevron_right
Incidence of Haemophilus influenzae type b meningitis during 18 years of vaccine use: observational study using routine hospital data
Eeva Salo
BMJ, 2005
View PDFchevron_right
Haemophilus influenzae meningitis 5 years after introduction of the Haemophilus influenzae type b conjugate vaccine in Brazil
Guilherme Ribeiro
Vaccine, 2007
View PDFchevron_right
Strategies for immunization against invasive Haemophilus influenzae type b infection
Sten Iwarson
Vaccine, 1991
View PDFchevron_right
Immunogenicity and safety of the Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine co-administered with human rotavirus, hepatitis A and 13-valent pneumococcal conjugate vaccines: results from a phase III, randomized, multicenter study in...
Remon Abu-Elyazeed
Human Vaccines & Immunotherapeutics, 2018
View PDFchevron_right
Randomized Trial to Assess Immunogenicity and Safety of Haemophilus influenzae Type b and Neisseria meningitidis Serogroups C and Y–Tetanus Toxoid Conjugate Vaccine in Infants
Emmanuel Aris
Pediatric Infectious Disease Journal, 2010
View PDFchevron_right
Impact of Haemophilus influenzae Type b Conjugate Vaccine in South Africa and Argentina
Shabir Madhi
The Pediatric Infectious Disease Journal, 2004
View PDFchevron_right
Enhanced antibody responses in infants given different sequences of heterogeneous Haemophilus influenzae type b conjugate vaccines
Joel Ward
The Journal of Pediatrics, 1995
View PDFchevron_right
Efficacy of Haemophilus influenzae type b conjugate vaccines and persistence of disease in disadvantaged populations. The Haemophilus Influenzae Study Group
Javier Díez-Domingo
American Journal of Public Health, 1999
View PDFchevron_right
Haemophilus influenzae type b (Hib) vaccine: An effective control strategy in India.
Mohan Bairwa
Human …, 2011
View PDFchevron_right
Prevention of invasive Haemophilus influenzae type b disease: lessons from vaccine efficacy trials
Joel ward
Vaccine, 1991
View PDFchevron_right
Efficacy of Haemophilus influenzae type b vaccination of children: a meta-analysis
charles obonyo
European Journal of Clinical Microbiology & Infectious Diseases, 2006
View PDFchevron_right
Haemophilus influenzae type b conjugate vaccine trial in Oxford: implications for the United Kingdom
Lance Chilton
Archives of Disease in Childhood, 1989
View PDFchevron_right
Introducing new vaccines in developing countries: Concepts and approaches to estimating burden of Haemophilus influenzae type b-associated disease
Paul E Kilgore
Journal of Health Population and Nutrition
View PDFchevron_right
Lot-to-lot consistency, safety and immunogenicity of 3 lots of Haemophilus influenzae type b conjugate vaccine: results from a phase III randomized, multicenter study in infants
Remon Abu-Elyazeed
Vaccine, 2017
View PDFchevron_right
Effectiveness of Haemophilus influenzae type b vaccines
Brian Hutchison
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 1990
View PDFchevron_right
Effectiveness of a nationwide infant immunization program against Haemophilus influenzae b
Drora Fraser
Vaccine, 1999
View PDFchevron_right
Haemophilus influenzae type B conjugate vaccines
Rex Force
Annals of Pharmacotherapy
View PDFchevron_right
Impact of Introduction of the Haemophilus influenzae Type b Conjugate Vaccine into Childhood Immunization on Meningitis in Bangladeshi Infants
Nadira Sultana, Abdullah Baqui
View PDFchevron_right
Optimising the use of conjugate vaccines to prevent disease caused by Haemophilus influenzae type b, Neisseria meningitidis and Streptococcus pneumoniae
Mary Ramsay
VACCINE, 2008
View PDFchevron_right
Postlicensure effectiveness of the Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer-membrane protein complex conjugate vaccine among Navajo children
Raymond Reid
The Journal of Pediatrics, 1994
View PDFchevron_right
Response to conjugate Haemophilus influenzae B vaccine among infants in Niamey, Niger
Amadou Garba
The American journal of tropical medicine and hygiene, 1998
View PDFchevron_right